Keyphrases
Tissue Factor Pathway inhibitor-2 (TFPI-2)
100%
C-terminus
100%
Confidence Interval
42%
Factor V-short
42%
FV Leiden
28%
Prothrombinase
28%
Splice Variant
14%
Overexpression
14%
Healthy Volunteers
14%
Population-based Study
14%
Amsterdam
14%
Bleeding Risk
14%
Heterozygote
14%
Homozygote
14%
Overexpressing
14%
Bleeding
14%
Prothrombin
14%
Plasma Factors
14%
Thrombin Formation
14%
High Affinity
14%
Chromogenic Substrate
14%
Absorbance
14%
Factor V Leiden
14%
Material Factor
14%
Prothrombinase Complex
14%
Prothrombinase Activity
14%
Anticoagulant Mechanism
14%
C-terminal Peptide
14%
Method Factors
14%
Thrombosis Risk
14%
Preactivated
14%
INIS
tissues
100%
inhibition
100%
plasma
100%
affinity
28%
peptides
28%
levels
14%
risks
14%
thrombosis
14%
populations
14%
substrates
14%
splicing
14%
homozygotes
14%
heterozygotes
14%
anticoagulants
14%
thrombin
14%
prothrombin
14%
Biochemistry, Genetics and Molecular Biology
C-Terminus
100%
Tissue Factor Pathway Inhibitor
100%
Factor V
100%
Blood Plasma
100%
Prothrombinase
36%
Normal Human
9%
Population Research
9%
Homozygote
9%
Prothrombin
9%
Plasma Factor
9%
Factor V Leiden
9%
Thrombin
9%
Neuroscience
Blood Clotting Factor 5
100%
C-Terminus
100%
Blood Plasma
100%
Thromboplastin
63%
Blood Clotting Factor 10a
36%
Thrombin
9%
Prothrombin
9%
Antithrombotic
9%
Anticoagulant
9%
Blood Clotting Factor 5 Leiden
9%
Immunology and Microbiology
Blood Plasma
100%
Carboxy Terminal Sequence
100%
Thromboplastin
100%
Peptides
28%
Normal Human
14%
Population Research
14%
Plasma Factor
14%
Homozygote
14%
Thrombin
14%
Pharmacology, Toxicology and Pharmaceutical Science
Tissue Factor Pathway Inhibitor
100%
Blood Clotting Factor 5
100%
Blood Clotting Factor 10a
36%
Normal Human
9%
Anticoagulant Agent
9%
Bleeding
9%
Thrombin
9%
Population Study
9%
Thrombosis
9%
Prothrombin
9%
Mating Hormone Alpha Factor
9%
Blood Clotting Factor 5 Leiden
9%
Chromogenic Substrate
9%